C4 Therapeutics, Inc. (CCCC)
3.815
+0.08
(+2.01%)
USD |
NASDAQ |
Sep 04, 13:14
C4 Therapeutics Net Income (Annual) : -104.99M for Dec. 31, 2025
Net Income (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -104.99M |
| December 31, 2024 | -105.32M |
| December 31, 2023 | -132.49M |
| December 31, 2022 | -128.18M |
| Date | Value |
|---|---|
| December 31, 2021 | -83.89M |
| December 31, 2020 | -66.34M |
| December 31, 2019 | -34.10M |
| December 31, 2018 | -15.71M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Annual) Benchmarks
| Beam Therapeutics, Inc. | -79.99M |
| Rallybio Corp. | -8.978M |
| Q32 Bio, Inc. | 29.82M |
| Arrowhead Pharmaceuticals, Inc. | 30.11M |
| Oncolytics Biotech, Inc. | -28.76M |